WEDNESDAY, June 8, 2022 — The optimal combined intake of omega-3 fatty acids associated with reductions in blood pressure (BP) appears to be between 2 and 3 g/day, according to a meta-analysis published in the June 7 issue of the Journal of the American Heart Association.
Xin Zhang, Ph.D., from the Macau University of Science and Technology in China, and colleagues conducted a systematic review to examine the association between omega-3 fatty acids and BP. Data were included from 71 trials of 4,973 individuals with a combined docosahexaenoic acid (DHA) + eicosapentaenoic (EPA) acid dose of 2.8 g/day (interquartile range, 1.3 to 3.6 g/day).
The researchers identified a nonlinear association overall, and in most subgroups, the association was depicted as J-shaped dose-response curves. Moderate doses of 2 to 3 g/day were the optimal intake for both systolic and diastolic BP reductions (−2.61 and −1.64 mm Hg for 2 g/day and −2.61 and −1.80 mm Hg for 3 g/day). Stronger and approximately linear dose-response relations among hypertensive, hyperlipidemic, and older populations were seen in subgroup studies.
“Our study supports the [U.S. Food and Drug Administration] guidance that EPA and DHA omega-3 fatty acids may reduce the risk of coronary heart disease by lowering high BP, especially among people already diagnosed with hypertension,” a coauthor said in a statement. “However, while our study may add a layer of credible evidence, it does not meet the threshold to make an authorized health claim for omega-3 fatty acids in compliance with FDA regulations.”
© 2022 HealthDay. All rights reserved.
Posted June 2022
More News Resources
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.